Stay updated on Pembrolizumab in Advanced Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page’s technical revision/version label was updated from v3.5.2 to v3.5.3, reflecting a minor site/build change rather than an update to the study record content.SummaryDifference0.0%

- Check13 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check43 days agoChange DetectedRevision: v3.5.0 was added. Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision from v3.4.2 to v3.4.3 was applied. The study page content and layout appear unchanged.SummaryDifference0.0%

- Check72 days agoChange DetectedAdded explicit mention of Gastric cancer and a Resources section linking to the Genetic and Rare Diseases Information Center; these are informational updates that do not alter core study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.4.2 added and the funding notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Advanced Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.